2024 STS Perioperative & Critical Care Conference
Activity Description
Attendees will explore the latest techniques and management strategies in cardiovascular and thoracic (CVT) critical care and enhanced recovery after surgery (ERAS). This two-day event features dynamic and interactive presentations, hands-on demonstrations, scientific abstracts, and expert panel discussions designed for all members of the CVT perioperative and critical care team.
This activity contains the Overall Evaluation required for physicians and PAs to claim CME credit for attending the 2024 STS Perioperative & Critical Care Conference, held in Philadelphia, PA.
Nurses claiming CE with Corexcel, see below.
Corexcel Continuing Education Information
Corexcel is approved as a provider of continuing nursing education, California provider #CEP 13687.
Corexcel is approved as a provider of continuing nursing professional development through the Florida Board of Nursing, provider #50-452, and reports completions to CE Broker.
This educational program provides a maximum of 14.25 contact hours.
Claiming Credit and Delivery of Certificate
You may claim your CE credit through the link below. Complete your participant information, select the sessions you attended, and complete the conference evaluation.
www.corexcel.com/ce-process/sts-ccs.php
Your continuing education credit certificate will be sent as a PDF to the email address you provide during the evaluation process. Certificates will be processed on November 30, 2024.
Help/Questions
For questions, comments or help obtaining your continuing education certificate, please contact:
Corexcel
302-477-9730
learn@corexcel.com
www.corexcel.com
Target Audience
This conference is designed for all members of the cardiothoracic critical care team, including but not limited to surgeons, cardiologists, interventionalists, intensivists, anesthesiologists, hospitalists, critical care nurses, nurse practitioners, perioperative registered nurses, physician assistants, catheter lab technicians, perfusionists, pharmacists, nutritionists, administrative leads, physical/occupational therapists, respiratory therapists. In addition, surgical residents and cardiothoracic surgical fellows in training are encouraged to attend.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the elements of Enhanced Recovery After Surgery (ERAS), including:
- How to implement an enhanced recovery protocol.
- Methodologies for patient blood management, avoiding acute kidney injury, and reducing opioids for perioperative analgesia.
- How to measure the effectiveness of an ERAS program.
- Evaluate strategies for optimizing the interaction and engagement of the interdisciplinary team during ICU rounds.
- Discuss newer metric of evaluation of healthcare team performance.
- Demonstrate techniques in ECMO management, use of ultrasound for cardiac and intravascular volume status in postoperative patients, and management of postoperative cardiac emergencies.
- Describe elements of contemporary perioperative management of the heart failure patient.
- Explain the organization of the shock team.
- Describe the diagnosis and management of:
- Vasoplegia
- Advanced ventilation strategies for the post-operative cardiac surgery patient.
Refer to the STS Education Disclosure Policy. The individuals below have disclosed whether they have financial relationships with ineligible companies in the past 24 months. All relevant financial relationships have been mitigated.
Planning Committee
Rakesh Arora, MD, PhD (Co-chair)
University Hospitals Cleveland Medical Center
Financial Relationships: Edwards Lifesciences, HLS Therapeutics, Inc., Bioporto – Consultant/Advisory Board
Subhasis Chatterjee, MD (Co-chair)
Baylor College of Medicine
Financial Relationships: Nothing to Disclose
Daniel Engelman, MD
UMASS Chan medical School – Baystate
Financial Relationships: Edwards Lifesciences, Medela, Arthrex, Atricure, Pharmacosmos – Consultant/Advisory Board, Alexion, Genentech, RenalGuard – Research
Michael Grant, MD, MSE
Johns Hopkins University
Financial Relationships: Nothing to Disclose
Alexander Gregory, MD
Cumming School of Medicine, University of Calgary
Financial Relationships: Edwards Lifesciences – Research Grant
Sameer Hirji, MD, MPH
Brigham and Women’s Hospital
Financial Relationships: Nothing to Disclose
Bo Kim, MD
University of Texas – Austin
Financial Relationships: Nothing to Disclose
Mark Martin, CCP
HCA North Florida
Financial Relationships: Nothing to Disclose
Vicki Morton-Bailey, DNP, APRN, AGNP-BC
Providence Anesthesiology Associates
Financial Relationships: Edwards Lifesciences – Consultant
Amanda Rea, DNP, CRNP
University of Maryland St. Joseph Medical Center
Financial Relationships: Edwards Lifesciences – Speakers Bureau
Amanda Rhee, MD, MS
Mount Sinai Hospital
Financial Relationships: Nothing to Disclose
Faculty
Christian Bermudez, MD
University of Pennsylvania
Financial Relationships: Abbott, Abiomed – Consultant/Advisory Board
Mauer Biscotti, MD
University of Pennsylvania
Financial Relationships: Nothing to Disclose
Marisa Cevasco, MD
University of Pennsylvania
Financial Relationships: Abiomed – Speakers Bureau/Honoraria
Sung-Min Cho, DO, MHS
Johns Hopkins University
Financial Relationships: Nothing to Disclose
Cheryl Crisafi, MSN, RN, CNL
Baystate Medical Center
Financial Relationships: Nothing to Disclose
Kari DiVito, DPT
West Virginia University
Financial Relationships: Nothing to Disclose
Emily Gordon, MD, MSEd
University of Pennsylvania
Financial Relationships: Nothing to Disclose
Matthew Griffee, MD
University of Utah
Financial Relationships: Nothing to Disclose
Jeremiah A. Hayanga, MD, MPH, FACS, FRCS, FCCP, FCCM
West Virginia University
Financial Relationships: Nothing to Disclose
Steven Keller, MD, PhD
Johns Hopkins University
Financial Relationships: Abiomed – Consultant, X-COR Therapeutics, Inc. – Ownership Interest
Pinki Patel, DNP, CRNP, APC-HQS
University of Pennsylvania
Financial Relationships: Nothing to Disclose
Rawn Salenger, MD
University of Maryland St. Joseph Medical Center
Financial Relationships: Arthrex, Encare, Zimmer, La Jolla – Consultant, Atricure – Speakers Bureau/Honoraria and Consultant/Advisory Board, Artivion – Speakers Bureau/Honoraria
Andrew Shaw, MD
Cleveland Clinic
Financial Relationships: Edwards Lifesciences, Genentech, Novartis, Retia, Alexion, Abiomed, RenalGuard – Consultant/Advisory Board
Audrey Spelde, MD
University of Pennsylvania
Financial Relationships: Nothing to Disclose
Wilson Szeto, MD
University of Pennsylvania
Financial Relationships: Abbott, Artivion, Edwards Lifesciences, Medtronic, Terumo Aortic –Research Grant, Speakers Bureau/Honoraria, Consultant/Advisory Board
Nicholas Teman, MD
University of Colorado
Financial Relationships: Alexion Pharmaceuticals – Research Grant, Speakers Bureau/Honoraria, Consultant/Advisory Board
Asad Usman, MD, MPH
University of Pennsylvania
Financial Relationships: Nothing to Disclose
Melissa Vogelsong, MD
Stanford University
Financial Relationships: Nothing to Disclose
Alison Ward, MD
Emory University
Financial Relationships: Nothing to Disclose
Glenn J.R. Whitman, MD
Johns Hopkins University
Financial Relationships: Avania – Consultant, GWBN, LLC – Ownership Interest
Akram Zaaqoq, MD
University of Virginia
Financial Relationships: Nothing to Disclose
STS Staff
The following staff have NOT had any financial relationships with any ineligible companies in the past 24 months.
Anne Friedman
Education Manager
Meredith Herzog
Associate Director of Education
Scott Bradbury
Vice President of Education
Elisa Robles-Gnet
Meetings & Conventions Manager
Melisa Puthenmadom
E-Learning Coordinator
Caitlin Golden
Marketing Manager
Chris Bukowski
Meeting Coordinator
The Society of Thoracic Surgeons is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Society of Thoracic Surgeons designates this live activity for a maximum of 14.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants (PAs) may claim a maximum of 14.25 AMA PRA Category 1 Credits™ for completing this activity.
Corexcel Continuing Education Information
Corexcel is approved as a provider of continuing nursing education, California provider #CEP 13687.
Corexcel is approved as a provider of continuing nursing professional development through the Florida Board of Nursing, provider #50-452, and reports completions to CE Broker.
This educational program provides a maximum of 14.25 contact hours.
Claiming Credit and Delivery of Certificate
You may claim your CE credit through the link below. Complete your participant information, select the sessions you attended, and complete the conference evaluation.
www.corexcel.com/ce-process/sts-ccs.php
Your continuing education credit certificate will be sent as a PDF to the email address you provide during the evaluation process. Certificates will be processed on November 30, 2024.
Help/Questions
For questions, comments or help obtaining your continuing education certificate, please contact:
Corexcel
302-477-9730
learn@corexcel.com
www.corexcel.com
Available Credit
- 14.25 ABS Accredited CME
- 14.25 ABTS Accredited CME
- 14.25 AMA PRA Category 1 Credit™